Consistent with Ernst et al study [13], survival analysis on both TCGA GBM dataset (n = 528) and Xiangya dataset (n = 60) revealed that GBM patients with high EMP3 expression exhibited shorter overall survival than EMP3-low patients (Figure 1E). This evidence concerns the gene EMP3 and glioblastoma.